• Live
    • Audio Only
  • google plus
  • facebook
  • twitter
News > Cuba

Cuba: President Praises Alzheimer’s Treatment

  • Cuban President Miguel Díaz-Canel praises Cuban scientists. March. 9, 2022.

    Cuban President Miguel Díaz-Canel praises Cuban scientists. March. 9, 2022. | Photo: Twitter/@MediccGail

Published 9 March 2022
Opinion

The conditional sanitary registration of the NeuroEpo molecule for mild and moderate Alzheimer's disease was approved in Cuba by the national regulatory entity. 

Cuban President Miguel Díaz-Canel expressed his admiration for Cuban science, praising its scientists for doing such great work regarding the product developed by the Molecular Engineering Center (CIM). 

RELATED:
Americans Demand End of US Blockade Against Cuba

The registration was granted by the Center for the State Control of Medicines, Equipment and Medical Devices. It will be valid for three years, starting from the date of issue of the registration certificate, informed the general director of the CIM, Eduardo Ojito.

After obtaining the results of the third phase of the clinical efficacy study, its registration was confirmed. The authorization request must be submitted within a period not exceeding six months, stated the general director.

Cuban President Miguel Díaz-Canel today praised the approval by the national regulatory entity of the conditional sanitary registration of the NeuroEpo molecule for mild and moderate Alzheimer's disease.

These statements were made at the usual meeting held every Tuesday at the Palace of the Revolution. Scientists and experts from the Ministry of Public Health (MINSAP) discussed the significance of the recent conditional sanitary registration approval. 

During the meeting, the head of state noted that post-pandemic priorities include addressing neurodevelopmental disorders in children. 


 

Comment
0
Comments
Post with no comments.